Category: Corporate NewsBy adminMay 17, 2022 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:Rameda Reports its 1Q22 ResultsNextNext post:Disclosure to EGX regarding molecule acquisitionRelated PostsEarnings Release One-Pager 4Q24March 10, 2025Earning Release One Pager 3Q24November 14, 2024Rameda Completes Largest Acquisition to DateSeptember 30, 2024Rameda Announces the Establishment of Glow: A Strategic Expansion into the Thriving Freely Priced Cosmeceutical MarketSeptember 9, 2024Earning Release One Pager 2Q24August 13, 2024Rameda Announces Price Increase Approvals for All Its Top ProductsAugust 7, 2024
Rameda Announces the Establishment of Glow: A Strategic Expansion into the Thriving Freely Priced Cosmeceutical MarketSeptember 9, 2024
